Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis

BACKGROUND: Plasminogen activator inhibitor-1 (PAI-1) is considered to be involved in the physiopathological mechanisms of Alzheimer's disease (AD), metabolic syndrome (MetS), and female infertility. Previous studies investigating the association between PAI-14G/5G (rs1799889) gene polymorphism...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Gao, Bai, Xu, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738113/
https://www.ncbi.nlm.nih.gov/pubmed/33327353
http://dx.doi.org/10.1097/MD.0000000000023660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738113/
https://www.ncbi.nlm.nih.gov/pubmed/33327353
http://dx.doi.org/10.1097/MD.0000000000023660

Ejemplares similares